Search

everythinglearnresearchcommunity

for

Search:↓

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Pregnant and breastfeeding women should get COVID-19 vaccines for safety and protection.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

The method effectively delivers vaccines through the skin without needles.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Vaccination is crucial for managing Covid-19 despite new virus strains.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

People in high-income countries are more likely to accept COVID-19 booster doses than those in middle or low-income countries.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

COVID-19 vaccines can cause minor skin reactions, including those related to Bullous Pemphigoid, but these usually resolve on their own.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Covid-19 vaccination during pregnancy is safe for mothers and babies.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Removing breast implants resolved the patient's symptoms.

New vaccine technologies are improving global health by making vaccines more effective and long-lasting.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Provenge extends prostate cancer survival by about 4 months.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

BCC can protect heart cells from damage caused by oxidative stress.

CMV infection increases the risk of GvHD after bone marrow transplants.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.